Compound information
- Natural Products
- ZC2458551
- Molecular Formula
- C26H41N3O5
- Molecular Weight
- 475.304621412 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1R)-1-[[(1R)-1-[[(1R)-1-formyl-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamate
- InChI
- InChI=1S/C26H41N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,15,17-19,21-23H,12-14,16H2,1-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22-,23-/m1/s1
- InChI Key
- TZYWCYJVHRLUCT-DNVJHFABSA-N
- SMILES
- CC(C)C[C@H](C=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCc1ccccc1
- Source
- ZINC000028338288
Warheads
- Carbamate
-
- Aldehydic carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 34 | Ring Count | 1 |
Heteroatom Count | 8 | Rotatable Bond Count | 14 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 113.6 Å2 | LogP | 4.585 |
LogS | -4.047 | LogD | 5.268 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.995 | Pgp substrate | 0.124 |
HIA | 0.961 | F20 % | 0.992 |
F30 % | 0.871 | Caco-2 | -4.779 |
MDCK | -4.828 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.065 | PPB | 55.82 |
VD | 0.811 | Fu | 1.656 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.004 | CYP1A2 substrate | 0.475 |
CYP2A6 substrate | 0.22 | CYP2B6 substrate | 0.342 |
CYP2C19 inhibitor | 0.751 | CYP2C19 substrate | 0.523 |
CYP2C8 substrate | 0.583 | CYP2C9 inhibitor | 0.345 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.151 |
CYP2D6 substrate | 0.224 | CYP2E1 substrate | 0.328 |
CYP3A4 inhibitor | 0.96 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.835 | CL | 5.467 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.003 | Hepatotoxicity | 0.967 |
Mutagenicity | 0.379 | Rat Oral Acute Toxicity | 0.847 |
FDAMDD | 0.101 | Skin Sensitization | 0.921 |
Carcinogenicity | 0.214 | Eye Corrosion | 0.005 |
Eye Irritation | 0.032 | Respiratory Toxicity | 0.032 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.39 | IGC50 | 3.36 |
LC50FM | 4.559 | LC50DM | 4.816 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.278 | NR-AR-LBD | 0.404 |
NR-AhR | 0.006 | NR-Aromatase | 0.039 |
NR-ER | 0.385 | NR-ER-LBD | 0.362 |
NR-PPAR-gamma | 0.346 | SR-ARE | 0.565 |
SR-ATAD5 | 0.268 | SR-HSE | 0.044 |
SR-MMP | 0.031 | SR-p53 | 0.068 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.